A Trial of Grazax in Subjects With Hayfever

PHASE3CompletedINTERVENTIONAL

Enrollment

329

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

October 31, 2007

Conditions

Allergy

Interventions

DRUG

Grazax

Tablets 75,000 SQT and matching placebo. One tablet daily.

Trial Locations (1)

CompleWare Corporation, Iowa City

All Listed Sponsors

lead

ALK-Abelló A/S

INDUSTRY

NCT00421655 - A Trial of Grazax in Subjects With Hayfever | Biotech Hunter | Biotech Hunter